Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-031309
Filing Date
2025-03-04
Accepted
2025-03-04 06:24:17
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amlx-20241231.htm   iXBRL 10-K 3301192
2 EX-10.11 amlx-ex10_11.htm EX-10.11 249817
3 EX-19.1 amlx-ex19_1.htm EX-19.1 150309
4 EX-21.1 amlx-ex21_1.htm EX-21.1 16803
5 EX-23.1 amlx-ex23_1.htm EX-23.1 3688
6 EX-31.1 amlx-ex31_1.htm EX-31.1 17454
7 EX-31.2 amlx-ex31_2.htm EX-31.2 16903
8 EX-31.3 amlx-ex31_3.htm EX-31.3 17443
9 EX-32.1 amlx-ex32_1.htm EX-32.1 9890
10 EX-32.2 amlx-ex32_2.htm EX-32.2 9649
11 EX-32.3 amlx-ex32_3.htm EX-32.3 9102
12 EX-97.1 amlx-ex97_1.htm EX-97.1 66716
13 GRAPHIC img111464628_0.jpg GRAPHIC 490796
  Complete submission text file 0000950170-25-031309.txt   14569854

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amlx-20241231.xsd EX-101.SCH 1804619
107 EXTRACTED XBRL INSTANCE DOCUMENT amlx-20241231_htm.xml XML 2183195
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41199 | Film No.: 25701355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)